| Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ... The Lancet Neurology 18 (12), 1091-1102, 2019 | 1539 | 2019 |
| A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of … A McQuillin, M Rizig, HMD Gurling Pharmacogenetics and genomics 17 (8), 605-617, 2007 | 172 | 2007 |
| Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets DA Kia, D Zhang, S Guelfi, C Manzoni, L Hubbard, RH Reynolds, J Botía, ... JAMA neurology 78 (4), 464-472, 2021 | 116 | 2021 |
| Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset KJ Billingsley, IA Barbosa, S Bandrés-Ciga, JP Quinn, VJ Bubb, ... npj Parkinson's Disease 5 (1), 8, 2019 | 99 | 2019 |
| Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability RH Reynolds, J Botía, MA Nalls, J Hardy, SA Gagliano Taliun, M Ryten npj Parkinson's Disease 5 (1), 6, 2019 | 91 | 2019 |
| The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease S Bandres‐Ciga, S Saez‐Atienzar, L Bonet‐Ponce, K Billingsley, D Vitale, ... Movement Disorders 34 (4), 460-468, 2019 | 78 | 2019 |
| A threonine to isoleucine missense mutation in the pericentriolar material 1 gene is strongly associated with schizophrenia SR Datta, A McQuillin, M Rizig, E Blaveri, S Thirumalai, G Kalsi, ... Molecular psychiatry 15 (6), 615-628, 2010 | 68 | 2010 |
| PDXK mutations cause polyneuropathy responsive to pyridoxal 5′‐phosphate supplementation V Chelban, MP Wilson, J Warman Chardon, J Vandrovcova, MN Zanetti, ... Annals of Neurology 86 (2), 225-240, 2019 | 67 | 2019 |
| Penetrance of Parkinson's Disease in LRRK2 p.G2019S Carriers Is Modified by a Polygenic Risk Score H Iwaki, C Blauwendraat, MB Makarious, S Bandrés‐Ciga, HL Leonard, ... Movement Disorders 35 (5), 774-780, 2020 | 61 | 2020 |
| The genetic architecture of Parkinson disease in Spain: characterizing population‐specific risk, differential haplotype structures, and providing etiologic insight S Bandres‐Ciga, S Ahmed, MS Sabir, C Blauwendraat, ... Movement Disorders 34 (12), 1851-1863, 2019 | 54 | 2019 |
| A gene expression and systems pathway analysis of the effects of clozapine compared to haloperidol in the mouse brain implicates susceptibility genes for schizophrenia MA Rizig, A McQuillin, A Ng, M Robinson, A Harrison, M Zvelebil, SP Hunt, ... Journal of psychopharmacology 26 (9), 1218-1230, 2012 | 44 | 2012 |
| Investigation of autosomal genetic sex differences in Parkinson's disease C Blauwendraat, H Iwaki, MB Makarious, S Bandres‐Ciga, HL Leonard, ... Annals of neurology 90 (1), 35-42, 2021 | 41 | 2021 |
| Failure to confirm genetic association between schizophrenia and markers on chromosome 1q23. 3 in the region of the gene encoding the regulator of G‐protein signaling 4 protein … MA Rizig, A McQuillin, V Puri, K Choudhury, S Datta, S Thirumalai, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 141 …, 2006 | 40 | 2006 |
| Underrepresented populations in Parkinson's genetics research: current landscape and future directions AF Schumacher‐Schuh, A Bieger, O Okunoye, KY Mok, SY Lim, ... Movement Disorders 37 (8), 1593-1604, 2022 | 31 | 2022 |
| Comparing fluid biomarkers of Alzheimer's disease between African American or Black African and white groups: A systematic review and meta-analysis A Chaudhry, M Rizig Journal of the Neurological Sciences 421, 117270, 2021 | 25 | 2021 |
| Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study M Rizig, S Bandres-Ciga, MB Makarious, OO Ojo, PW Crea, OV Abiodun, ... The Lancet Neurology 22 (11), 1015-1025, 2023 | 23 | 2023 |
| Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson’s disease EE Brown, C Blauwendraat, J Trinh, M Rizig, MA Nalls, E Leveille, ... Neurobiology of Aging 97, 148. e17-148. e24, 2021 | 22 | 2021 |
| Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson disease NU Okubadejo, M Rizig, OO Ojo, H Jonvik, O Oshinaike, E Brown, ... PLoS One 13 (12), e0207984, 2018 | 21 | 2018 |
| WARS2 mutations cause dopa-responsive early-onset parkinsonism and progressive myoclonus ataxia M Skorvanek, I Rektorova, W Mandemakers, M Wagner, R Steinfeld, ... Parkinsonism & Related Disorders 94, 54-61, 2022 | 19 | 2022 |
| The international Parkinson disease genomics consortium Africa M Rizig, N Okubadejo, M Salama, O Thomas, A Akpalu, R Gouider The Lancet Neurology 20 (5), 335, 2021 | 19 | 2021 |
